ADAPTIVE BIOTECHNOLOGIES CORPORATION Tenant Improvements
ADAPTIVE BIOTECHNOLOGIES CORPORATION (ADPT) had Tenant Improvements of $600.00 thousand as of 2020-03-31, per its 10-Q filed 2020-05-12.
Financial Statements › Balance Sheet › Assets
us-gaap:TenantImprovements · last filed 2026-02-26
- 2020-03-31: Tenant Improvements $600.00K.
- 2018-04-30: Tenant Improvements $2.40M.
| Period end | Tenant Improvements |
|---|---|
| 2020-03-31 | $600.00K 10-Q · filed 2020-05-12 |
| 2018-04-30 | $2.40M 10-K · filed 2026-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | United States | $4.897B | -6.51 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |